Clinical trial

Comparison Between Metformin and Glyburide in the Management of Gestational Diabetes

NCT06589141

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention MetFORMIN 500 Mg Oral Tablet Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record GlyBURIDE 2.5 MG Oral Tablet Normalized identity: glyburide 2.5 MG Oral TabletView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Comparison Between Metformin and Glyburide in the Management of Gestational Diabetes

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2025-01-01

PhaseNA

Conditions

Gestational Diabetes Mellitus in Pregnancyunresolved

Interventions

MetFORMIN 500 Mg Oral TabletDRUG

GlyBURIDE 2.5 MG Oral TabletDRUG · verified · RxNorm: glyburide 2.5 MG Oral Tablet

Sponsors & collaborators

Assiut Universitylead sponsor

Middle-Eastern College of Obstetricians and Gynecologistscollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06589141 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.